By By Michael McGuffin, President, American Herbal Products Association (AHPA)
Each New Year presents an opportunity to take stock of where we are and to reevaluate our priorities for the near- and long-term future. We each make our resolutions and then motivate ourselves to meet our goals, whether modest or lofty. With 2021 upon...
The effusion of natural products connected to COVID-19 is nothing new. Plant-based remedies have played a central part in all of the pandemics in human history, a Spanish researcher maintains.
As coronavirus cases trend back up in the United States demand for botanical ingredients to support immunity will continue unabated, a panel discussion concluded yesterday.
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a string of warnings against a number of herbal medicines sold online and containing ingredients not authorised for the sale in the UK.
Implementing better growing and manufacturing processes along with increasing the use of modern analytical techniques and greater international regulation would ‘undoubtedly’ reduce the issues surrounding the quality of herbal extracts, say researchers.
The Alliance for Natural Health (ANH) has taken a swipe at the newly formed Herbal Quality Campaign (QHC) in the UK, labelling its concerns about herbal food supplements “bogus”.
UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), says investigations are ongoing into a number of ‘borderline’ herbal products, and that its enforcement actions are not being swayed by recent European Union court decisions.
A legal challenge to new EU legislation, implemented on May 1, which could ban thousands of traditional herbal medicines is “imminent,” a spokesperson for the UK-based Alliance for Natural Health told NutraIngredients.
The European Union Traditional Herbal Medicinal Products Directive (THMPD) – fully implemented across the bloc after a seven-year transition period over the weekend – has been welcomed by German and French trade groups, even as opposition mounts against...
UK herbal medicine and dietary supplement firm Bio-Health says that larger industry players in particular have no excuse for failing to register products under the new EC regulation governing herbal medicines.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) is reveiewing the process by which herbal products are transferred from the existing system to that established by the European Union Traditional Herbal Medicinal Products Directive (THMPD).
A Medicines and Healthcare products Regulatory Agency (MHRA) commissioned survey has found 77 per cent of adults believe botanical medicines should be regulated.
Use of herbal medicine in German and France is the most widespread
in Europe, according to a report published in the New England
Journal of Medicine yesterday.
The use of herbal medicines entails risks, but probably fewer than
with synthetic drugs, argues a British Medicial Journal
editorial out tomorrow. And failing to fund further studies on
herbals represents the biggest risk to consumers,...
Members of the UK's herbal industry have proposed an overhaul of
current legislation to ensure stricter standards and safety for
those products not regulated by the new European Traditional
Medicinal Herbals directive.
European members of parliament have adopted a resolution for new
legislation on traditional herbal products which will require all
herbal medicines on sale in the European Union to be registered.
Australian scientists are investigating new ways to mass-produce
the active ingredients found in the herbal medicines echinacea,
ginseng and gynostemma.
The growing trend towards the use of alternative herbal treatments
has prompted the United Arab Emirates to warn consumers about the
potential health risks involved in using unregistered medicines.
